|
HBS1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7116308370646E-12 |
| Normal-vs-Stage2 |
4.44680000044606E-07 |
| Normal-vs-Stage3 |
1.62458935193399E-12 |
| Normal-vs-Stage4 |
1.62481139653892E-12 |
| Stage1-vs-Stage2 |
6.118400E-01 |
| Stage1-vs-Stage3 |
8.595300E-03 |
| Stage1-vs-Stage4 |
4.783800E-03 |
| Stage2-vs-Stage3 |
2.127800E-01 |
| Stage2-vs-Stage4 |
1.431190E-01 |
| Stage3-vs-Stage4 |
6.608000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.81443748914489E-12 |
| Normal-vs-Asian |
1.483910E-03 |
| Caucasian-vs-AfricanAmerican |
2.117800E-01 |
| Caucasian-vs-Asian |
9.265000E-01 |
| AfricanAmerican-vs-Asian |
5.307800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.69433389330243E-13 |
| Male-vs-Female |
3.466000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.49339999997189E-06 |
| Normal-vs-Age(41-60Yrs) |
2.44249065417534E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.29590005393254E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.972800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.548000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.595200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.987400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.753600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.886040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.294160E-01 |
| Normal-vs-Grade 2 |
8.28204171909874E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.027250E-01 |
| Grade 1-vs-Grade 3 |
1.763990E-03 |
| Grade 1-vs-Grade 4 |
4.609700E-04 |
| Grade 2-vs-Grade 3 |
5.607400E-04 |
| Grade 2-vs-Grade 4 |
2.025600E-04 |
| Grade 3-vs-Grade 4 |
1.505750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.22340000247223E-08 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
4.18279999969684E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65423230669148E-12 |
| Normal-vs-N1 |
7.249600E-04 |
| N0-vs-N1 |
1.814230E-01 |
|
|
